BioProtect Ltd., a proprietary technology platform company, provides innovative biodegradable spacers. The technology may suit a wide range of clinical applications including spacing for radiation oncology protection and general surgery.
BioProtect vision is to provide safer and improved clinical outcomes for patients undergoing radiation therapy.
BioProtect’s first application commercially available in Europe and other territories outside the USA, is the ProSpace™ Balloon Spacer, acting as a spacer for the protection of healthy tissue, in patients receiving radiotherapy for prostate cancer. The company is currently undergoing clinical study in the United States.
The ProSpace™ Balloon Spacer is an easy-to-deploy, bioabsorbable balloon that separates healthy tissue from treated organs during radiation oncology treatments. This allows physicians to kill cancerous cells at any modality including escalated, hypofractionated doses while sparing healthy tissue.
BioProtect is ISO 13485 certified and has the CE Mark for its ProSpace™ Balloon Implant.
Brands: ProSpace™ Balloon Spacer, acting as a spacer for the protection of healthy tissue, in patients receiving radiotherapy for prostate cancer.